- Home
- STRR vs KLTO Comparison
STRR vs KLTO Comparison
Compare STRR & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- KLTO
- Stock Information
- Founded
- STRR 1985
- KLTO 2019
- Country
- STRR United States
- KLTO United States
- Employees
- STRR N/A
- KLTO N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- KLTO
- Sector
- STRR Health Care
- KLTO
- Exchange
- STRR Nasdaq
- KLTO NYSE
- Market Cap
- STRR 6.3M
- KLTO 5.9M
- IPO Year
- STRR N/A
- KLTO N/A
- Fundamental
- Price
- STRR $2.10
- KLTO $1.23
- Analyst Decision
- STRR Strong Buy
- KLTO
- Analyst Count
- STRR 1
- KLTO 0
- Target Price
- STRR $5.00
- KLTO N/A
- AVG Volume (30 Days)
- STRR 15.1K
- KLTO 13.6M
- Earning Date
- STRR 08-12-2025
- KLTO 08-15-2025
- Dividend Yield
- STRR N/A
- KLTO N/A
- EPS Growth
- STRR N/A
- KLTO N/A
- EPS
- STRR N/A
- KLTO N/A
- Revenue
- STRR $57,165,000.00
- KLTO N/A
- Revenue This Year
- STRR $33.64
- KLTO N/A
- Revenue Next Year
- STRR $22.87
- KLTO N/A
- P/E Ratio
- STRR N/A
- KLTO N/A
- Revenue Growth
- STRR 34.33
- KLTO N/A
- 52 Week Low
- STRR $1.72
- KLTO $0.11
- 52 Week High
- STRR $5.00
- KLTO $3.91
- Technical
- Relative Strength Index (RSI)
- STRR 56.12
- KLTO N/A
- Support Level
- STRR $1.95
- KLTO N/A
- Resistance Level
- STRR $2.20
- KLTO N/A
- Average True Range (ATR)
- STRR 0.06
- KLTO 0.00
- MACD
- STRR 0.03
- KLTO 0.00
- Stochastic Oscillator
- STRR 61.54
- KLTO 0.00
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.